At a glance
ClinicalIndex Comparison RecordN/ACompleted· 15 enrolled
Drug / intervention
Hyperbaric oxygen therapyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Hyperbaric Oxygen Therapy on Oxidative Stress and Inflammation in Patients With Diabetic Foot Ulcers
In Brief
An observational study evaluating Hyperbaric oxygen therapy for Diabetic Foot Ulcer Neuropathic. Completed, enrolled 15 participants across 1 site.
Detailed Summary
This study seeks to assess changes in genes that are related to inflammation and oxidative stress in patients with type 2 Diabetes with diabetic foot treated with hyperbaric chamber
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Foot Ulcer Neuropathic
CountriesMexico
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartJan 2019
Primary CompletionJan 2020
Study CompletionJul 2020
First PostedJul 2024
TodayJul 2026
First PostedJul 16, 2024
Enrollment StartJan 15, 2019
Primary CompletionJan 15, 2020
Study CompletionJul 15, 2020
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 2.0 years ago
Interventions
Hyperbaric oxygen therapyother
Series of 30 HBOT sessions of 60 minutes at 2 ATA in the hyperbaric chamber for five consecutive days per week.